PACB - PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

1.13
0.040   3.540%

Share volume: 7,759,598
Last Updated: 04-28-2025
Measuring And Control Equipment/Lab Analytical Instruments: -0.04%

PREVIOUS CLOSE
CHG
CHG%
$1.09
0.04
0.04%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
23%
Profitability 15%
Dept financing 16%
Liquidity 52%
Performance 25%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-0.88%
1 Month
-4.24%
3 Months
-27.56%
6 Months
-45.15%
1 Year
-29.38%
2 Year
-90.01%
Key data
Stock price
$1.13
P/E Ratio 
0.00
DAY RANGE
$1.09 - $1.15
EPS 
-$0.91
52 WEEK RANGE
$1.07 - $2.72
52 WEEK CHANGE
-$31.52
MARKET CAP 
501.170 M
YIELD 
N/A
SHARES OUTSTANDING 
272.529 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-08-2025
BETA 
1.19
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$7,528,979
AVERAGE 30 VOLUME 
$8,645,325
Company detail
CEO: Christian O. Henry
Region: US
Website: pacb.com
Employees: 730
IPO year: 2010
Issue type: Common Stock
Market: XNAS
Industry: Measuring And Control Equipment/Lab Analytical Instruments
Sector: Manufacturing

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. PacBio's Systems conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow.

Recent news
loading